Clinical Trial Update: FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FOLFOXIRI as neoadjuvant chemotherapy for high-risk locally advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: West China Hospital | Conditions: High-risk Locally Advanced Colorectal Cancer, Neoadjuvant Chemotherapy | Phase 2 | Status: UNKNOWN